Trade Setup Buy Target $5.58 Sell Target $6.65 Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and Wheat Yield traits. It also provides nutritional oils […]
Read MoreTrade Setup Buy Target $4.05 Sell Target $4.79 Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids.
Read MoreThis sector boasts both value and growth plays, and one trader says the group is “starting to fire on all cylinders.”
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.73 Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used for the inflammatory […]
Read MorePlus, diplomatic tensions are rising between the U.S. and China, Netflix said the real competition in the streaming wars is with “linear TV,” and Morgan Stanley reported earnings.
Read MoreGoldman Sachs says October has historically been 25% more volatile since 1928.
Read MorePlus, Philip Morris and Altria called off their merger, WeWork’s CEO stepped down, and Saudi Aramco is finally going public.
Read MorePlus, good news out of Hong Kong, Hurricane Dorian is making its way to the U.S., and Box shares are soaring.
Read MoreThese 4 plays may be investors’ best best now.
Read MorePowell finally spoke, China retaliated, Hasbro just bought the owner of Peppa Pig, and this stock was just named Guggenheim’s “best idea.”
Read MoreAnd the 5 stocks hedge funds are buying in this sector now.
Read MoreIf you’re thinking about buying the dip in stocks, Jim Cramer says these 2 stocks are buys right now.
Read MoreTrade Setup Buy Target $37.79 Sell Target $39.36 Stop Loss $35.34 Weis Markets, Inc. engages in the retail sale of food in Pennsylvania and surrounding states. The company’s retail food stores sell groceries, dairy products, frozen foods, meats, seafood, fresh produce, floral, pharmacy services, deli products, prepared foods, bakery products, beer and wine, and fuel; […]
Read MoreTrade Setup Buy Target $5.01 Sell Target $5.86 Trailing Stop 20% cbdMD, Inc. produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under […]
Read MoreTrade Setup Buy Target $5.29 Sell Target $6.07 Trailing Stop 20% Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company offers vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid […]
Read More